1-Iagnocco A, Ceccarelli F, Mennini M, et al. Subclinical synovitis detected by ultrasound in children affected by coeliac disease: a frequent manifestation improved by a gluten-free diet. Clin Exp Rheumatol. 2014;32:137-42.
2. Nakano S, Mishiro T, Takahara S, et al. Distinct expression of mast cell tryptase and protease activated receptor-2 in synovia of rheumatoid arthritis and osteoarthritis. Clin Rheumatol. 2007;26:1284-92.
3. Ruschpler P, Lorenz P, Eichler W, et al. High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis. Arthritis Res Ther. 2003;5:R241-52.
4. Suurmond J, Dorjée AL, Boon MR, Knol EF, Huizinga TW, Toes RE, Schuerwegh AJ. Mast cells are the main interleukin 17-positive cells in anticitrullinated protein antibody-positive and -negative rheumatoid arthritis and osteoarthritis synovium. Arthritis Res Ther. 2011;13(5):R150. Epub 2011 Sep 20.
5. Shin K, Nigrovic PA, Crish J, Boilard E, McNeil HP, Larabee KS, et al. Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes.J Immunol. 2009;182(1):647–656.
6. Karsh J, Chen Y, Lin M, Dales R. The association between allergy and rheumatoid arthritis in the Canadian population. Eur J Epidemiol. 2005;20(9):783-7.
7. Francis J, Carty JE, Scott BB. The prevalence of coeliac disease in rheumatoid arthritis. Eur J Gastroenterol Hepatol. 2002;14:1355-6.
8. Castillo-Ortiz JD, Durán-Barragán S, Sánchez-Ortíz A, Ramos-Remus C. [Anti-transglutaminase, antigladin and ultra purified anti-gladin antibodies in patients with a diagnosis of rheumatoid arthritis]. Reumatol Clin. 2011;7:27-9.
9. Williams R. Rheumatoid arthritis and food: a case study. (Br Med J (Clin Res Ed). 1981;283(6290):563.
10. Hafström I, Ringertz B, Spångberg A, et al. A vegan diet free of gluten improves the signs and symptoms of rheumatoid arthritis: the effects on arthritis correlate with a reduction in antibodies to food antigens. Rheumatology (Oxford). 2001;40:1175-9.
11. van de Laar MA, Aalbers M, Bruins FG, et al. Food intolerance in rheumatoid arthritis. II. Clinical and histological aspects. Ann Rheum Dis. 1992;51:303-6.
12. O’Farrelly C, Price R, McGillivray AJ, Fernandes L. IgA rheumatoid factor and IgG dietary protein antibodies are associated in rheumatoid arthritis. Immunol Invest. 1989 ;18:753-64.
13. Lidén M, Kristjánsson G, Valtysdottir S, Venge P, Hällgren R. Self-reported food intolerance and mucosal reactivity after rectal food protein challenge in patients with rheumatoid arthritis. Scand J Rheumatol. 2010;39:292-8.
14. Karatay S, Erdem T, Kiziltunc A, et al. General or personal diet: the individualized model for diet challenges in patients withrheumatoid arthritis. Rheumatol Int. 2006;26:556-60. Epub 2005 Jul 16.
15. Riente L, Chimenti D, Pratesi F,et al. Antibodies to tissue transglutaminase and Saccharomyces cerevisiae in ankylosing spondylitis and psoriatic arthritis. J Rheumatol. 2004;31:920-4.
16. Peskett SA, Platts-Mills TA, Ansell BM, Stearnes GN. Incidence of atopy in rheumatic disease. J Rheumatol. 1981;8:321-4.
17. Zhang WM, Xu LY, Lu YM, Cao LF. Atopy in children with systemic onset juvenile idiopathic arthritis (SoJIA) is associated with a worse outcome. Immunopharmacol Immunotoxicol. 2014;36:176-81.
18. Lepore L, Pennesi M, Ventura A,et al. Anti-alpha-gliadin antibodies are not predictive of celiac disease in juvenile chronic arthritis. Acta Paediatr. 1993 ;82:569-73.
19. Stagi S, Giani T, Simonini G, Falcini F. Thyroid function, autoimmune thyroiditis and coeliac disease in juvenile idiopathic arthritis. Rheumatology (Oxford). 2005;44:517-20.
20. Al-Mayouf SM, Al-Mehaidib AI, Alkaff MA. The significance of elevated serologic markers of celiac disease in children with juvenilerheumatoid arthritis. Saudi J Gastroenterol. 2003;9:75-8.
21. Gheita TA, Fawzy SM, Nour El-D in AM, Gomaa HE. Asymptomatic celiac sprue in juvenile rheumatic diseases children. Int J Rheum Dis. 2012;15:220-6.
22. Ratner D, Eshel E, Vigder K. Juvenile rheumatoid arthritis and milk allergy. J R Soc Med. 1985;78:410-3.
23. Schrander JJ, Marcelis C, de Vries MP, van Santen-Hoeufft HM. Does food intolerance play a role in juvenile chronic arthritis? Br J Rheumatol. 1997;36:905-8.
24. Shen TC, Lin CL, Wei CC. Et al.,-The risk of asthma in patients with ankylosing spondylitis: a population-based cohort study. PLoS One. 2015;10(2):e0116608.
25. Noordenbos T, Yeremenko N, Gofita I, et al. Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis. Arthritis Rheum. 2012;64:99-109.
26. Iqbal T, Zaidi MA, Wells GA, Karsh J. Celiac disease arthropathy and autoimmunity study. J Gastroenterol Hepatol. 2013;28:99-105.
27. Kallikorm R, Uibo O, Uibo R. Coeliac disease in spondyloarthropathy: usefulness of serological screening. Clin Rheumatol. 2000;19:118-22.
28. Toğrol RE, Nalbant S, Solmazgül E,et al. The significance of coeliac disease antibodies in patients with ankylosing spondylitis: a case-controlled study. J Int Med Res. 2009;37:220-6.
29. Teichmann J, Voglau MJ, Lange U. Antibodies to human tissue transglutaminase and alterations of vitamin D metabolism in ankylosing spondylitis and psoriatic arthritis. Rheumatol Int. 2010;30:1559-63.
30. Appelboom T, Durez P. Effect of milk product deprivation on spondyloarthropathy. Ann Rheum Dis. 1994;53:481-2.
31. Azevedo DC, Ferreira GA, Carvalho MA.IgA nephropathy in patients with spondyloarthritis followed-up at the Rheumatology Service of Hospital das Clínicas/UFMG. Rev Bras Reumatol. 2011 Sep-Oct;51(5):417-22.
32. Kloster Smerud H, Fellström B, Hällgren R,et al. Gastrointestinal sensitivity to soy and milk proteins in patients with IgA nephropathy. Clin Nephrol. 2010;74:364-71.
33. Kamanli A, Ardicoglu O, Godekmerdan A. HLA-b27 subtypes in patients with spondylarthropathies, IgE levels against some allergens and their relationship to the disease parameters. Bratisl Lek Listy. 2009;110(8):480-5.
34. Andretta MA, Vieira TD, Nishiara R, Skare TL. Anti-Saccharomyces cerevisiae (ASCA) and anti-endomysial antibodies in spondyloarthritis. Rheumatol Int. 2012;32:551-4.
35. Aikawa NE, Jesus AA, Liphaus BL, et al. Organ-specific autoantibodies and autoimmune diseases in juvenile systemic lupus erythematosus and juveni le dermatomyositis patients. Clin Exp Rheumatol. 2012;30:126-31.
36. Dema B, Pellefigues C, Hasni S et al. Autoreactive IgE is prevalent in systemic lupus erythematosus and is associated with increased disease activity and nephritis. PLoS One. 2014;9:e90424.
37. de Lucena GR, Gonçalves RT, Braz AS, Freire EA. Systemic lupus erythematosus and allergy: an integrative review of the literature. Acta Reumatol Port. 2013;38:162-70.
38. Pellefigues C, Charles N. The deleterious role of basophils in systemic lupus erythematosus. Curr Opin Immunol. 2013;25:704-11.
39. Freeman HJ. Adult celiac disease followed by onset of systemic lupus erythematosus. J Clin Gastroenterol. 2008;42:252-5.
40. Rensch MJ, Szyjkowski R, Shaffer RT,et al. The prevalence of celiac disease autoantibodies in patients with systemic lupus erythematosus. Am J Gastroenterol. 2001;96:1113-5.
41. Mankaï A, Sakly W, Thabet Y,et al. Anti-Saccharomyces cerevisiae antibodies in patients with systemic lupus erythematosus. Rheumatol Int. 2013;33:665-9.
42. Yukawa S, Yamaoka K, Sawamukai N, et al. Dermal mast cell density in fingers reflects severity of skin sclerosis in systemic sclerosis. Mod Rheumatol. 2013;23:1151-7.
43. de Paulis A, Valentini G, Spadaro G, et al. Human basophil releasability. VIII. Increased basophil releasability in patients with scleroderma. Arthritis Rheum. 1991;34:1289-96.
44. Nisihara R, Utiyama SR, Azevedo PM, Skare TL. Celiac disease screening in patients with scleroderma. Arq Gastroenterol. 2011;48:163-4.
45. Forbess LJ, Gordon JK, Doobay K,et al. Low prevalence of coeliac disease in patients with systemic sclerosis: a cross-sectional study of a registry cohort. Rheumatology (Oxford). 2013;52:939-43.
46. Rosato E, De Nitto D, Rossi C, et al. High incidence of celiac disease in patients with systemic sclerosis. J Rheumatol. 2009;36:965-9.
47. Himi T, Takano K, Yamamoto M, Naishiro Y, Takahashi H. A novel concept of Mkulicz’s disease as IgG4-related disease. Auris Nasus Larynx. 2012;39:9-17.
48. Skopouli FN, Li L, Boumba D, Stefanaki S, Hanel K, Moutsopoulos HM, Krilis SA. Association of mast cells with fibrosis and fatty infiltration in the minor salivary glands of patients with Sjögren’s syndrome. Clin Exp Rheumatol. 1998 ;16:63-5.
49. Szodoray P, Barta Z, Lakos G, Szakáll S, Zeher M. Coeliac disease in Sjögren’s syndrome–a study of 111 Hungarian patients. Rheumatol Int. 2004;24:278-82.
50. Iltanen S, Collin P, Korpela M,et al. Celiac disease and markers of celiac disease latency in patients with primary Sjögren’ssyndrome. Am J Gastroenterol. 1999;94:1042-6.
51. Lidén M, Kristjánsson G, Valtýsdóttir S, Hällgren R. Gluten sensitivity in patients with primary Sjögren’s syndrome. Scand J Gastroenterol. 2007;42:962-7.
52. Lidén M, Kristjánsson G, Valtysdottir S, Venge P, Hällgren R. Cow’s milk protein sensitivity assessed by the mucosal patch technique is related to irritable bowel syndrome in patients with primary Sjögren’s syndrome. Clin Exp Allergy. 2008;38:929-35.
53. Sackesen C, Bakkaloglu A, Sekerel BE,et al. Decreased prevalence of atopy in paediatric patients with familial Mediterranean fever. Ann Rheum Dis. 2004 ;63:187-90.
54. Yazici A, Orge Gonullu E, Kardes B, Cefle A. The prevalence of atopy in patients with familial Mediterranean fever and Behçet’s disease. Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):68-70. Epub 2013 Sep 9.
55. Kelly SJ, Uri AJ, Freeland HS, et al. Effects of colchicine on IgE-mediated early and late airway reactions. Chest. 1995 ;107:985-91.
56. Kuloğlu Z, Ozçakar ZB, Kirsaçlioğlu C,et al. Is there an association between familial Mediterranean fever and celiac disease? Clin Rheumatol. 2008 ;27:1135-9.
57. Makay B, Unsal E. .Does breast-feeding affect severity of familial Mediterranean fever Clin Rheumatol. 2009;28:1389-93.
58. Gao C. Clinical pathological analysis of recurrent oral ulcer and Behçet’s syndrome. Zhonghua Kou Qiang Yi Xue Za Zhi. 1990;25:82-5.
59. Lichtig C, Haim S, Hammel I, Friedman-Birnbaum R. The quantification and significance of mast cells in lesions of Behçet’s disease. Br J Dermatol. 1980;102:255-9.
60. Haim S, Sobel JD, Friedman-Birnbaum R, Lichtig C. Histohogical and direct immunofluorescence study of cutaneous hyperreactivity in Behçet’sdisease. Br J Dermatol. 1976;95:631-6.
61. Onat AM, Buyukhatipoglu H, Yilmaz M, et al. Immunoglobulin E: a new diagnostic clue for Behçet’s disease? IgE and Behçet’s disease. Clin Rheumatol. 2007;26:81-3.
62. Caldas CA, Lage LV, de Carvalho JF. Behçet’s disease associated with celiac disease: a very rare association. Rheumatol Int. 2010;30:523-5.
63. Zamani F, Shahram F, Shakeri R, et al. Prevalence of celiac disease among patients with Behcet’s disease in Iran. Dig Dis Sci. 2009;54:1736-9.
64. Triolo G, Accardo-Palumbo A, Dieli F, et al. Humoral and cell mediated immune response to cow’s milk proteins in Behçet’s disease. Ann Rheum Dis. 2002;61:459-62.
65. Krause I, Monselise Y, Milo G, Weinberger A. Anti-Saccharomyces cerevisiae antibodies–a novel serologic marker for Behçet’s disease. Clin Exp Rheumatol. 2002 ;20(4 Suppl 26):S21-4.
66. Fresko I, Ugurlu S, Ozbakir F, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behçet’s syndrome. Clin Exp Rheumatol. 2005 ;23(4 Suppl 38):S67-70.
67. Filik L, Biyikoglu I. Differentiation of Behcet’s disease from inflammatory bowel diseases: anti-Saccharomyces cerevisiae antibody and anti-neutrophilic cytoplasmic antibody. World J Gastroenterol. 2008 ;14:7271.
68. Monselise A, Weinberger A, Monselise Y,et al. Anti-Saccharomyces cerevisiae antibodies in Behçet’s disease–a familial study. Clin Exp Rheumatol. 2006 ;24(5 Suppl 42):S87-90.
69. Di Benedetto N, Muñoz SA, Albertón V, et al . Celiac disease in 3 patients with Takayasu’s arteritis .Reumatol Clin. 2011;7:255-7
70. Ozbakir F, Ugurlu S, Celik AF, Seyahi E. Anti-Saccharomyces cerevisiae (ASCA) and anti-neutrophil cytoplasmic (ANCA) antibodies are not increased in Takayasu arteritis. Acta Reumatol Port. 2011;36:20-3.
71. Delbrel X, Le-Bougeant P, Etienne G, et al. Celiac disease and autoimmune diseases or systemic disease. Six cases and a review of the literature. Ann Med Interne (Paris). 2003;154:197-204.
72. Squintani G, Ferrari S, Caramaschi P, et al. Multineuropathy in a patient with HBV infection, polyarteritis nodosa and celiac disease. Rheumatol Int. 2009;29:579-81.
73. Morfín-Maciel B, Medina A, Espinosa Rosales F, Berrón R, Huerta López J. Central nervous system involvement in a child with polyarteritis nodosa and severe atopic dermatitis. Rev Alerg Mex. 2002; 49:189-95.
74. Ando M, Miyazaki E, Ishii T, et al. Incidence of myeloperoxidase anti-neutrophil cytoplasmic antibody positivity and microscopicpolyangitis in the course of idiopathic pulmonary fibrosis. Respir Med. 2013;107:608-15.
75. Suzuki H, Fujita T, Fuke Y, Yabuki M, Kajiwara M, et al (2013) A case of ANCA-associated vasculitis with glomerular eosinophilic infiltration: a possible pathogenic implication. Mod Rheumatol 23:564-71.
76.Travis WD, Hoffman GS, Leavitt RY, Pass HI, Fauci AS (1991) Surgical pathology of the lung in Wegener’s granulomatosis. Review of 87 open lung biopsies from 67 patients. Am J Surg Pathol 15:315-33.
77. Choopong P, Khan N, Sangwan VS, et al. Eosinophil activation in Wegener’s granulomatosis: a harbinger of disease progression? Ocul Immunol Inflamm. 2005;13:439-45.
78. Shu Y, Tang JP, Zhang D, Zeng YH, Zhou B. Investigation of allergens in 3,504 children with allergic diseases. Zhongguo Dang Dai Er Ke Za Zhi. 2010;12:720-2.
79. Chen O, Zhu XB, Ren P, et al. Henoch Schonlein Purpura in children: clinical analysis of 120 cases. Afr Health Sci. 2013 ;13:94-9 .
80. Schröder T, Fuchss J, Schneider I, Stoltenburg-Didinger G, Hanisch F. Eosinophils in hereditary and inflammatory myopathies. Acta Myol. 2013;32:148-53.
81. Shrestha S, Wershil B, Sarwark JF, et al. Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells. Arthritis Rheum. 2010;62:2813-22.
82. Konno T, Umeda Y, Umeda M, et al. A case of inflammatory myopathy with widely skin rash following use of supplements containing Spirulina Rinsho Shinkeigaku. 2011;51:330-3.
83. Song MS, Farber D, Bitton A, et al. Dermatomyositis associated with celiac disease: response to a gluten-free diet. Can J Gastroenterol. 2006;20:433-5.
84. Selva-O’Callaghan A, Casellas F, de Torres I,et al. Celiac disease and antibodies associated with celiac disease in patients with inflammatory myopathy.Muscle Nerve. 2007;35:49-54.
85. Hadjivassiliou M, Chattopadhyay AK, Grünewald RA,et al. Myopathy associated with gluten sensitivity. Muscle Nerve. 2007;35:443-50.
86. Zhang Z, Cherryholmes G, Mao A, et al. High plasma levels of MCP-1 and eotaxin provide evidence for an immunological basis offibromyalgia. Exp Biol Med (Maywood). 2008 ;233:1171-80.
87. Blanco I, Béritze N, Argüelles M, et al. Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients. Clin Rheumatol. 2010;29:1403-12.
88. Lucas HJ, Brauch CM, Settas L, Theoharides TC. Fibromyalgia–new concepts of pathogenesis and treatment. Int J Immunopathol Pharmacol. 2006;19:5-10.
89. Rodrigo L, Blanco I, Bobes J, de Serres FJ. Remarkable prevalence of coeliac disease in patients with irritable bowel syndrome plusfibromyalgia in comparison with those with isolated irritable bowel syndrome: a case-finding study.Arthritis Res Ther. 2013;15:R201. . [Epub ahead of print]
90. Tovoli F, Giampaolo L, Caio G,et al. Fibromyalgia and coeliac disease: a media hype or an emerging clinical problem? Clin Exp Rheumatol. 2013;31(6 Suppl 79):S50-2.
91. Taubman B, Mamula P, Sherry DD. Prevalence of asymptomatic celiac disease in children with fibromyalgia: a pilot study. Pediatr Rheumatol Online J. 2011;9:11.
92. Berstad A, Undseth R, Lind R, Valeur J. Functional bowel symptoms, fibromyalgia and fatigue: a food-induced triad? Scand J Gastroenterol. 2012;47:914-9.
93. Nanji AA, Freeman HJ, Anderson FH. Paralysis and rhabdomyolysis: a presenting feature of celiac disease. West J Med. 1982;136:273-4.
94. Paul V, Shamah S, Garankina O, Wolf L, Shia Lin Y. Rhabdomyolysis after fish consumption: Haff’s disease. QJM. 2014;107:67-8.
96.Isasi C, Colmenero I, Casco F, et al. Fibromyalgia and non-celiac gluten sensitivity: a description with remission of fibromyalgia. Rheumatol Int. 2014;34:1607-12.
97. Volta U. Gluten-free diet in the management of patients with irritable bowel syndrome, fibromyalgia and lymphocytic enteritis. Arthritis Res Ther. 2014;16:505.
